I will not bother taking Marrone Bio Innovations (MBII) to court. The company is young and inexperienced in dealing with SEC rules and shareholder advocates, such as myself. However, I cannot give them a complete pass. Below is a draft of my remarks to be delivered to those attending the January 31 Annual Meeting. Today is the last day to vote online. Please see Marrone Bio Innovations, Inc: Proxy Vote for my recommendations. Continue Reading →
Tag Archives | Marrone Bio Innovations
Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. Without changes, Marrone Bio is likely to continue to lag the Nasdaq, as it has done for the last one, two and five year time periods. While the Nasdaq has gone up over 100% in the last five years, Marrone Bio has gone down over 90%. Proxy access could make our board more directly accountable to shareholders.
The annual meeting that was supposed to be held in 2017 is set for January 31, 2018 in Davis, California. There is very little data available though my usual sources because Marrone Bio is such a small company. I voted with the Board’s recommendations 67% of the time. View Proxy Statement via SEC’s EDGAR system (look for DEF 14A). Continue Reading →
MBII, Marrone Bio Innovations, Inc., was added to the Russell Microcap Index after the market closed on June 23, 2017. Hopefully, that will provide some needed stability to this volatile stock, so it is great news. However, corporate governance concerns remain. For example, when will our company hold the 2017 annual meeting?
MBII Has Plenty of Positives
According to Dr. Pamela Marrone, Founder and CEO of Marrone Bio Innovations,
We are very pleased to have joined the Russell Microcap Index. This is an important milestone for Marrone Bio Innovations and represents an opportunity to increase our visibility within the public market investment community.
A new report and scorecard grades 20 of the largest food retailers in the U.S on their policies and practices regarding pollinator protection, organic offerings and pesticide reduction. Of the top food retailers, 17 received an “F” for failing to have a publicly available policy to reduce or eliminate pesticide use to protect pollinators. Only Aldi, Costco (COST) and Whole Foods (WFM) received passing grades in this category. Continue Reading →
Marrone Bio Settles Class Action: Announcement
Marrone Bio settles class action; time to move on. Marrone Bio Innovations, Inc. (the “Company”) (NASDAQ:MBII, $MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, recently announced the Company and other defendants, including certain of the Company’s current and former officers and directors, have reached an agreement to settle the private securities class action litigation consolidated in the U.S. District Court for the Eastern District of California on February 13, 2015 as Special Situations Fund III QP, L.P. et al v. Marrone Bio Innovations, Inc. et al, Case No 2:14-cv-02571-MCE-KJN.
The agreement is subject to review and approval by the court after notice and an opportunity to object are provided to the plaintiff class. The settlement agreement contains no admission or concession of wrongdoing or liability by the Company or any other defendant and includes a full release of claims. The agreement provides for a settlement payment to the class of $12,000,000, which will be paid by insurance carriers. Accordingly, the settlement of these lawsuits will have no adverse impact on the Company’s financial position or operations. Continue Reading →
Marrone Bio Innovations, Inc. $MBII provides bio-based pest management and plant health products for the agriculture, turf, and ornamental and water treatment markets in the United States and internationally. Marrone Bio is one of the stocks in my portfolio. Their annual meeting is on December 17, 2015. ProxyDemocracy.org had collected the votes of one fund when I checked. I voted with the Board’s recommendations 33% of the time. View Proxy Statement.
Marrone Bio Innovations (MBII): is one of the stocks in my portfolio. Their annual meeting is coming up on 5/29/2014. ProxyDemocracy.org had collected the votes of two funds when I checked and voted on 5/23/2014. I voted with management 33% of the time. View Proxy Statement. Read Warnings below. What follows are my proxy voting recommendations for MBII. Continue Reading →